MD Anderson Cancer Center

Intratumoral delivery of an engineered oncolytic virus (DNX-2401) targeting glioblastoma (GBM) cells combined with subsequent immunotherapy was safe and notably improved survival outcomes in a subset of patients with recurrent GBM, according to results fr

CAR T-cell therapy is a type of immunotherapy that genetically modifies a patient's own T cells to recognize and destroy cancer. It

Women with early-stage breast cancer who had an intermediate risk recurrence score (RS) from a 21-gene expression assay had similar outcomes, regardless of whether they received chemotherapy, a new study from The University of Texas MD Anderson Cancer fin

The Cancerwise podcast features insights from UT MD Anderson experts on cancer diagnosis and treatment, research breakthroughs, and prevention, as well as stories...

Many of Aetna's plans (including some listed above) have customized networks which may or may not include UT MD Anderson. Please call the telephone number on the back of your insurance card to verify if UT MD Anderson in included in your plan's specific n